Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2041584-99-8Sofosbuvir Impurity 23

● In Stock

Catalogue No.:	VE0022928
CAS No.:	2041584-99-8
Mol. Formula:	C10H13FN2O5
Mol. Weight:	260.22 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 2041584-99-8

Parent drug

Sofosbuvir

IUPAC Name

1-((2S, 3R, 4R, 5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2, 4(1H, 3H)-dione

Pharmacopoeial Synonyms

N/A

Other Synonyms

1-[(2R)-2-Deoxy-2-fluoro-2-methyl-a-D-erythro-pentofuranosyl]-2, 4(1H, 3H)-pyrimidinedione

Smiles

OC[C@H]1O[C@H](N(C=CC(N2)=O)C2=O)[C@@](F)(C)[C@@H]1O

InChI

InChI=1S/C10H13FN2O5/c1-10(11)7(16)5(4-14)18-8(10)13-3-2-6(15)12-9(13)17/h2-3, 5, 7-8, 14, 16H, 4H2, 1H3, (H, 12, 15, 17)/t5-, 7-, 8+, 10-/m1/s1

Description

Sofosbuvir Impurity 23 is a meticulously characterized reference material that complies with rigorous regulatory requirements | including those defined by USP | EMA | JP | and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial manufacturing of Sofosbuvir. It is further supported by a detailed Structure Elucidation Report (SER) | ensuring high accuracy and reliability across a broad range of analytical applications.